Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

"I am excited to join Jasper's Board at an important phase in the company's growth," said Dr. Lucas. "I believe that briquilimab has the potential to serve as an important and differentiated therapeutic in a large number of diseases, and I look forward to contributing to Jasper's continued progress in delivering more treatment options to patients in need." About Jasper Certain statements included in this press release that are not historical facts are forward-looking statements for purposes of the safe harb ...